X-linked inhibitor of apoptosis protein levels and protein kinase C activity regulate the sensitivity of human endometrial carcinoma cells to tumor necrosis factorα-induced apoptosis

Endocrinology

Volumn 149, Issue 8, 2008, Pages 3789-3798

  Van Themsche, Céline ^a   Lafontaine, Lyne ^a   Asselin, Eric ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; PROTEIN KINASE B; PROTEIN KINASE C; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR 1; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL STRAIN; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG SENSITIVITY; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; TISSUE SECTION; UPREGULATION;

APOPTOSIS; CARCINOMA; DRUG RESISTANCE, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 47949128357     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0275     Document Type: Article

References (47)

1. Engel JB, Schally AV, Halmos G, Baker B, Nagy A, Keller G 2005 Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1. Cancer 104:1312-1321
2. Smith JA, Gaikwad A, Ramondetta LM, Wolf JK, Brown J 2006 Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines. Gynecol Oncol 103:518-522
3. Manna SK and Aggarwal BB 2000 All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-κB, activated protein-1 and apoptosis in human lung cancer cells. Oncogene 19:2110-2119
4. Nophar Y, Kemper O, Brakebusch C, Englemann H, Zwang R, Aderka D, Holtmann H, Wallach D 1990 Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 9:3269-3278
5. Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, Fiers W 1995 Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 154:2904-2913
6. Fotin-Mleczek M, Henkler F, Samel D, Reichwein M, Hausser A, Parmryd I, Scheurich P, Schmid JA, Wajant H 2002 Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 115:2757-2770
7. Hsu H, Shu HB, Pan MG, Goeddel DV 1996 TRADD-TRAF2 and TRADDFADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308
8. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM 1995 Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly-(ADP-ribose) polymerase. Cell 81:801-809
9. Laouar A, Glesne D, Huberman E 1999 Involvement of protein kinase C-β and ceramide in tumor necrosis factor-α-induced but not Fas-induced apoptosis of human myeloid leukemia cells. J Biol Chem 274:23526-23534
10. Sun Y, Mochizuki Y, Majerus PW 2003 Inositol 1,3,4-trisphosphate 5/6-kinase inhibits tumor necrosis factor-induced apoptosis. J Biol Chem 278:43645-43653
11. Lejeune FJ, Lienard D, Matter M, Ruegg C 2006 Efficiency of recombinant human TNF in human cancer therapy. Cancer Immunol 6:6-22
12. Tracey KJ, Lowry SF, Cerami A 1988 The pathophysiologic role of cachectin/TNF in septic shock and cachexia. Ann Inst Pasteur Immunol 139:311-317
13. Beesley JS, Kirby PL, Takeda S, Stackpoole A, Soutter WP, White JO 1998 The growth response to tumour necrosis factor α of human gynaecological cancer cell lines. Cytokine 10:432-440
14. Kirchebener P, Marth C, Mayer I, Daxenbichler G 1991 Metabolism of E1 and E2 in Ishikawa endometrium carcinoma cells: influence of TNFα. J Steroid Biochem Mol Biol 39:221-222
15. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC 1999 Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 18:5242-5251
16. Van Themsche C, Mathieu I, Parent S, Asselin E 2007 Transforming growth factor-β3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent up-regulation of X-linked inhibitor of apoptosis and protein kinase C-dependent induction of matrix metalloproteinase-9. J Biol Chem 282:4794-4802
17. Gagnon V, Van Themsche C, Turner S, Leblanc V, Asselin E 2008 Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. Apoptosis 13:259-271
18. Xiao CW, Ash K, Tsang BK 2001 Nuclear factor-κB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor α-induced apoptosis. Endocrinology 142:557-563
19. Rytomaa M, Lehmann K, Downward J 2000 Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene 19:4461-4468
20. St Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E 2004 Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int J Oncol 24:1311-1324
21. Dolcet X, Llobet D, Pallares J, Rue M, Comella JX, Matias-Guiu X 2005 FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis. Lab Invest 85:885-894
22. Seo KH, Lee HS, Jung B, Ko HM, Choi JH, Park SJ, Choi IH, Lee HK, Im SY 2004 Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-κB activation. Cancer Res 64:6482-6488
23. Watanabe Y, Shibata K, Kikkawa F, Kajiyama H, Ino K, Hattori A, Tsujimoto M, Mizutani S 2003 Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system. Clin Cancer Res 9:6497-6503
24. Chien W, Kumagai T, Miller CW, Desmond JC, Frank JM, Said JW, Koeffler HP 2004 Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 279:53087-53096
25. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM 1997 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem 272:17255-17257
26. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J 1997 Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195
27. Xiao CW, Yan X, Li Y, Reddy SA, Tsang BK 2003 Resistance of human ovarian cancer cells to tumor necrosis factor α is a consequence of nuclear factor κB-mediated induction of Fas-associated death domain-like interleukin-1β-converting enzyme-like inhibitory protein. Endocrinology 144:623-630
28. Gagnon V, Mathieu I, Sexton E, Leblanc K, Asselin E 2004 AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecol Oncol 94:785-795
29. Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN, Evers BM 2004 Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-κB (NF-κB)-inducing kinase/NF-κB pathway is linked to a default IκB-α autoregulatory loop. J Biol Chem 279:4285-4291
30. Medina EA, Afsari RR, Ravid T, Castillo SS, Erickson KL, Goldkorn T 2005 Tumor necrosis factor-α decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology 146:2726-2735
31. Asselin E, Mills GB, Tsang BK 2001 XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res 61:1862-1868
32. Jahani-Asl A, Basak A, Tsang BK 2007 Caspase-3-mediated cleavage of Akt: involvement of non-consensus sites and influence of phosphorylation. FEBS Lett 581:2883-2888
33. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J 1998 Nuclear factor (NF)-κB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor κ-induced apoptosis. J Exp Med 188:211-216
34. Vogler M, Durr K, Jovanovic M, Debatin KM, Fulda S 2007 Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells. Oncogene 26:248-257
35. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC 1998 IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215-2223
36. Shooner C, Caron PL, Frechette-Frigon G, Leblanc V, Dery MC, Asselin E 2005 TGF-β expression during rat pregnancy and activity on decidual cell survival. Reprod Biol Endocrinol 3:20
37. Du C, Fang M, Li Y, Li L, Wang X 2000 Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42
38. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG 2001 Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 3:128-133
39. Chen T, Yan W, Wells RG, Rimm DL, McNiff J, Leffell D, Reiss M 2001 Novel inactivating mutations of transforming growth factor-β type I receptor gene in head-and-neck cancer metastases. Int J Cancer 93:653-661
40. Lucke CD, Philpott A, Metcalfe JC, Thompson AM, Hughes-Davies L, Kemp PR, Hesketh R 2001 Inhibiting mutations in the transforming growth factor β type 2 receptor in recurrent human breast cancer. Cancer Res 61:482-485
41. Tran TA, Kallakury BV, Ambros RA, Ross JS 1998 Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma. Cancer 83:276-282
42. Llobet D, Eritja N, Encinas M, Llecha N, Yeramian A, Pallares J, Sorolla A, Gonzalez-Tallada FJ, Matias-Guiu X, Dolcet X 2007 CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells. Oncogene
43. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS 1998 NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683
44. Nishida S, Yoshioka S, Kinoshita-Kimoto S, Kotani M, Tsubaki M, Fujii Y, Tomura TT, Irimajiri K 2003 Pretreatment with PKC inhibitor triggers TNF-α induced apoptosis in TNF-α-resistant B16 melanoma BL6 cells. Life Sci 74:781-792
45. Shi RX, Ong CN, Shen HM 2005 Protein kinase C inhibition and X-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Cancer Res 65:7815-7823
46. Haranaka K, Sakurai A, Satomi N 1987 Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy. J Biol Response Mod 6:379-391
47. Balkwill FR, Ward BG, Moodie E, Fiers W 1987 Therapeutic potential of tumor necrosis factor-α and γ-interferon in experimental human ovarian cancer. Cancer Res 47:4755-4758